FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileRevelation Biosciences, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
REVBW
Revelation Biosciences, Inc. Stock AnalysisComprehensive stock analysis for Revelation Biosciences, Inc. (REVBW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisREVBW
REVBW
Revelation Biosciences, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
REVBW
  1. Home
  2. Stocks
  3. Revelation Biosciences, Inc.

Revelation Biosciences, Inc.

🇺🇸REVBW•NASDAQ

Revelation Biosciences, Inc.

🇺🇸REVBW•NASDAQ
Market cap
$27.25K

Your view on REVBW

Mkt Cap
$27.25K
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Revelation Biosciences, Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
James Rolke
Headquarters
4660 La Jolla Village Drive, San Diego, CA, US
Industry
Biotechnology
Sector
Healthcare
CEO
James Rolke
Headquarters
4660 La Jolla Village Drive, San Diego, CA, US
Description

Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering immunology-based therapies and diagnostic tools aimed at preventing and treating a range of illnesses.

Their flagship therapeutic, REVTx-99, is an intranasal immunomodulator designed to both prevent and treat a broad spectrum of respiratory viral infections, including SARS-CoV-2 (and its variants), influenza A and B, parainfluenza, rhinovirus, and RSV. Furthermore, its potential extends to addressing allergic rhinitis and chronic nasal congestion.

The company's pipeline also includes REVTx-200, an intranasal immunomodulator intended as an adjunct to enhance the efficacy of intramuscular vaccinations, thereby boosting immunity. Additionally, they are developing REVDx-501, a rapid diagnostic test designed for convenient home use to detect respiratory viral infections.

Established in 2019, the company is headquartered in New York, New York.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Revelation Biosciences, Inc.. Starting points for Revelation Biosciences, Inc.: EPS -$21.73, beta -0.12 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Revelation Biosciences, Inc.. Trailing twelve-month EPS for Revelation Biosciences, Inc. stands at -$21.73. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Revelation Biosciences, Inc.. Revelation Biosciences, Inc. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold REVBW12 companies
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
BVNRYBavarian Nordic A/SHealthcareOTC$2.4B
BXPHFBotanix Pharmaceuticals LimitedHealthcareOTC$89.0M
ARUXFAcrux LimitedHealthcareOTC$1.8M
ARVNArvinas, Inc.HealthcareNASDAQ$423.0M
ARWRArrowhead Pharmaceuticals, Inc.HealthcareNASDAQ$5.8B
ASBPAspire Biopharma Holdings, Inc.HealthcareNASDAQ$822,602
ASBPWAspire Biopharma Holdings, Inc.HealthcareNASDAQ$121,920
ASCLFAscletis Pharma Inc.HealthcareOTC$2.1B
ASEP.CNAsep Medical Holdings IncHealthcareCNQ—
ASMBAssembly Biosciences, Inc.HealthcareNASDAQ$454.4M
ASNDAscendis Pharma A/SHealthcareNASDAQ$16.6B
ASPEAspen Neuroscience Inc.HealthcareNASDAQ$361.2M
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Revelation Biosciences, Inc., and how their positions are changing. At a $27,251 market value, institutional positions materially move Revelation Biosciences, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Revelation Biosciences, Inc. executives and directors. Shares of Revelation Biosciences, Inc. have traded between $0.0098 and $0.01 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Revelation Biosciences, Inc.. Coverage tracks Revelation Biosciences, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Revelation Biosciences, Inc.

REVBW AnalysisWeak
Past
1
Growth
2
Health
4
Profit
1
Value
1